Calidi Biotherapeutics, Inc. Class of Warrant or Right, Outstanding
Calidi Biotherapeutics, Inc. (CLDI) had Class of Warrant or Right, Outstanding of 58.23 thousand shares as of 2024-07-26, per its 10-Q filed 2025-08-08.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2025-08-08
- 2024-07-26: Class of Warrant or Right, Outstanding 58.23K shares.
- 2020-11-30: Class of Warrant or Right, Outstanding 2.00B shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2024-07-26 | 58.23K shares 10-Q · filed 2025-08-08 |
| 2020-11-30 | 2.00B shares 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |